Icon

EPIRUBICIN HYDROCHLORIDE (nda050807)- (50MG/VIAL,200MG/VIAL)

EPIRUBICIN HYDROCHLORIDE HOSPIRA
50MG/VIAL,200MG/VIAL
No Yes
Expired Expired
None None
None No
Epirubicin Hydrochloride for Injection is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
0 0 0
Total Other Developers None
Drugs with Suitability No
50MG/VIAL ** ** - - -
200MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.